Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 149-159

  Tew, Kenneth D ^a   Monks, Anne ^b   Barone, Linda ^a   Rosser, Diane ^b   Akerman, Greg ^b   Montali, Julie A ^c   Wheatley, Jeffrey B ^c   Schmidt Jr , Donald E ^c  

^a FOX CHASE CANCER CENTER   (United States)

^b SAIC FREDERICK INC   (United States)

^c Terrapin Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER CELL CULTURE; DRUG RESISTANCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE; DATABASES, FACTUAL; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LACTOYLGLUTATHIONE LYASE; NATIONAL INSTITUTES OF HEALTH (U.S.); RNA, MESSENGER; SOFTWARE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UNITED STATES;

EID: 0029895281     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Tew, K. D. Glutathione associated enzymes in anticancer drug resistance. Cancer Res. 54:4313-4320 (1994).
2. Ciaccio, P. J., K. D. Tew, and F. B. LaCreta. The enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferase enzymes and inhibition by ethacrynic acid. Biochem. Pharmacol. 42:1504-1507 (1991).
3. Bolton, M. G., J. Hilton, K. D. Robertson, R. T. Streeper, O. M. Colvin, and D. A. Noe. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione. Drug Metab. Dispos. 21:986-996 (1993).
4. Suzuki, T., S. Smith, and P. G. Board. Structure and function of the 5′ flanking sequences of the human a class glutathione S-transferase genes. Biochem. Biophys. Res. Commun. 200:1665-1671 (1994).
5. Daniel, V. Glutathione S-transferases: gene structure and regulation of expression. Crit. Rev. Biochem. Mol. Biol. 28:173-207 (1993).
6. Seidegard, J., W. R. Vorachek, R. W. Pero, and W. R. Pearson. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA 85:7293-7297 (1988).
7. Kodate, C., A. Fukushi, T. Narita, H. Kudo, Y. Soma, and K. Sato. Human placental form of glutathione S-transferase (GST-π) as a new immunohistochemical marker for human colonic carcinoma. Jpn. J. Cancer Res. 77:226-229 (1986).
8. Tatematsu, M., H. Tsuda, T. Shirai, T. Masui, and N. Ito. Placental glutathione S-transferase (GST-P) as a new marker for hepatocarcinogenesis: in vivo short term screening for hepatocarcinogens. Toxicol. Pathol. 15:60-68 (1987).
9. Di Ilio, C., G. Del Boccio, A. Aceto, R. Casaccia, F. Mucilli, and G. Federici. Elevation of glutathione transferase activity in human lung tumor. Carcinogenesis 9:335-340 (1988).
10. Harrison, D. J., R. Kharbanda, D. Bishop, L. I. McLellan, and J. D. Hayes. Glutathione S-transferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry. Carcinogenesis 10:1257-1260 (1989).
11. Tsutsumi, M., T. Sugisaki, T. Makino, N. Miyagi, K. Nakatani, T. Shiratori, S. Takahashi, and Y. Konishi. Oncofetal expression of glutathione S-transferase placental form in human stomach carcinomas. Jpn. J. Cancer Res. 78:631-633 (1987).
12. Shiratori, Y., Y Somia, H. Maruyama, S. Sato, A. Takano, and K. Sato. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions. Cancer Res. 47:6806-6809 (1987).
13. Lee, W. H., R. A. Morton, J. I. Epstein, J. D. Brooks, P. A. Campbell, G. S. Bova, W. S. Hsieh, W. B. Isaacs, and W. G. Nelson. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 91:11733-11737 (1994).
14. Wheatley, J. B., M. K. Kelley, J. A. Montali, C. O. A. Berry, and D. E. Schmidt. Examination of glutathione S-transferase isoenzyme profiles in human liver using high-performance affinity chromatography. J. Chromatog. 663:53-63 (1994).
15. Montali, J. A., J. B. Wheatley, and D. E. Schmidt. Comparison of glutathione S-transferase levels in predicting the efficacy of a novel alkylating agent. Cell. Pharmacol. 2:241-247 (1995).
16. Kelley, M. K., A. Engqvist-Goldstein, J. A. Montali, J. B. Wheatley, D. E. Schmidt, and L. M. Kauvar. Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue. Biochem. J. 304:843-848 (1994).
17. Wheatley, J. B., B. Hughes, K. Bauer, and D. E. Schmidt, Study of chromatographic parameters for glutathione S-transferases on a highperformance liquid chromatography affinity stationary phase. J. Chromatog. 676:81-90 (1994).
18. Scopes, R. Measurement of protein by spectrophotometry at 205 nm. Anal. Biochem. 59:277-282 (1974).
19. Buck, M. A., T. A. Olah, C. J. Weitzmann, and B. S. Cooperman. Protein estimation by the product of integrated peak area and flow rate. Anal. Biochem. 182:295-299 (1989).
20. Wilce, M. C. J., and M. W. Parker. Structure and function of glutathione S-transferases. Biochim. Biophys. Acta 1205:1-18 (1994).
21. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
22. a subunit cDNA. Biochem. Biophys. Res. Commun. 141:229-237 (1986).
23. Toshiyki, K, M. Sakai, and M. Muramatsu. Structure and expression of a human class π glutathione S-transferase messenger RNA. Cancer Res. 47:5626-5630 (1987).
24. b subunit cDNA. Nucleic Acids Res. 16:8541-8554 (1988).
25. Godwin, A. K., A. Meister, P. J. O'Dwyer, C. S. Huang, T. C. Hamilton, and M. E. Anderson. High resistance to cisplatin in human ovarian cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA 89:3070-3074 (1992).
26. Gipp, J. J., C. Chang, and R. T. Mulcahy. Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthase. Biochem. Biophys. Res. Commun. 185:29-35 (1992).
27. Ranganathan, S., E. Walsh, A. K. Godwin, and K. D. Tew. Cloning and characterization of human colon glyoxalase-I. J. Biol. Chem. 268:5661-5667 (1993).
28. Ciaccio, P. J., A. K. Jaiswal, and K. D. Tew. Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics. J. Biol Chem. 269:15558-155562 (1994).
29. Masiakowski, P., R. Breathnach, J. Bloch, F. Gannon, A. Krust, and P. Chambon. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:7895-7903 (1982).
30. Laborda, J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res. 19:3998, 1991.
31. Tietze, F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized GSH: application to mammalian blood and other tissues. Anal. Biochem. 27:502-522 (1969).
32. Monks, A., D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, and M. R. Boyd. Feasibility of a high-flux anticancer drug screen utilizing a diverse panel of human tumor cell lines in culture. J. Natl. Cancer Inst. 83:757-766 (1991).
33. Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. Warren, H. Bokesch, S. Kenney, and M. Boyd. A new colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst. 82:1107-1112 (1990).
34. Paull, K. D., R. H. Shoemaker, L. Hodes, A. Monks, D. A. Scudiero, L. Rubinstein, J. Plowman, and M. R. Boyd. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 81:1088-1092 (1989).
35. Lee, J.-S., K. Paull, M. Alvarez, C. Hose, A. Monks, M. Grever, A. T. Fojo, and S. Bates. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol. 46:627-638 (1994).
36. Alvarez, M., K. Paull, A. Monks, C. Hose, J. S. Lee, J. Weinstein, M. Grever, S. Bates, and T. Fojo. Generation of a drug resistance profile by quantification of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J. Clin. Invest. 95:2205-2214 (1995).
37. Paull, K D., E. Hamel, and L. Malspeis. Prediction of biochemical mechanisms of action from the in vitro antitumor screen of the National Cancer Institute, in Cancer Chemotherapeutic Agents (W. Foye, ed.). ACS, Washington, DC (1995).
38. Weinstein, J., K. Kohn, M. Grever, V. Viswanadhan, L. Rubinstein, A. Monks, D. Scudiero, L. Welch, A. Koutsoukos, A. Chiausa, and K. Paull. Neural computing in cancer drug development: predicting mechanism of action. Science (Washington D. C.) 258:447-451 (1992).
39. Snedecor, G. W., and W. G. Cochran. Statistical Methods. Iowa State University Press, Ames, 186 (1980).
40. Steel, R. G. D., and J. H. Torrie. Principles and Procedures of Statistics: A Biomedical Approach. 2nd ed. McGraw-Hill Book Company, 578 (1980).
41. Lewis, A. D., I. D. Hickson, C. N. Robson, A. L. Harris, J. D. Hayes, S. A. Griffiths, M. M. Manson, A. E. Hall, J. E. Moss, and C. R. Wolf. Amplification and increased expression of α class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards. Proc. Natl. Acad. Sci. USA 85:8511-8515 (1988).
42. Shen, H., S. Ranganathan, S. Kuzmich, and K. D. Tew. The influence of ethacrynic acid on glutathione S-transferase transcript and protein half-life in human colon cancer cells. Biochem. Pharmacol. 50:1233-1238 (1995).
43. Bai, R. L., K. D. Paull, C. L. Herald, L. Malspeis, G. R. Pettit, and E. Hamel. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin: discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem. 266:15882-15889 (1991).
44. Paull, K. D., C. M. Lin, L. Malspeis, and E. Hamel. Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. Cancer Res. 52:3982-38900 (1992).
45. Leteurtre, F., G. Kohlhagen, K. D. Paull, and Y. Pommier. Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen. J. Natl. Cancer Inst. 86:1239-1244 (1994).
46. Finlay, G. J., E. Marshall, J. H. Matthews, K. D. Paull, and B. D. Baguley. In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance. Cancer Chemother. Pharmacol. 31:401-406, 1993.
47. Jayaram, H. N., G. Kharehbaghi, N. H. Jayaram, J. Rieser, K, Krohn, and K. D. Paull. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. Biochem. Biophys. Res. Commun. 186:1600-1606 (1992).
48. Cleaveland, E. S., A. Monks, A. Vaigro-Wolff, D. W. Zaharevitz, K. Paull, K. Ardalan, D. A. Cooney, and H. Ford, Jr. Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the COMPARE program. Biochem. Pharmacol. 49:947-954 (1995).
49. Paull, K. D., R. Camalier, S. A. Fitzsimmons, A. D. Lewis, P. Workman, and M. Grever. Correlations of DT-diaphorase expression with cell sensitivity data obtained from the NCI human tumor cell line panel. Proc. Am. Assoc. Cancer Res. 35:369 (1994).
50. Castro, V. M., M. Soderstrom, I. Carlberg, M. Widersten, A. Platz, and B. Mannervik. Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione-linked enzymes. Carcinogenesis 11:1569-1576 (1990).
51. Hao, X.-Y., V. M. Castro, J. Bergh, B. Sindstrom, and B. Mannervik. Isoenzyme-specific quantitative immunoassays for cytosolic glutathione transferases and measurement of the enzymes in blood plasma from cancer patients and in tumor cell lines. Biochim. Biophys. Acta 1225:223-230 (1994).
52. Singh, S. V., H. Ahmad, A. Kurosky, and Y. C. Awasthi. Purification and characterization of unique glutathione S-transferases from human muscle. Arch. Biochem. Biophys. 264:13-22 (1988).
53. Ali-Osman, F., and O. Akande. Isolation and characterization of cDNAs coding mRNAs of variant human glutathione S-transferase π genes in normal cells and gliomas. Biochim. Biophys. Acta, in press.
54. Kuzmich, S., L. A. Vanderveer,and K. D. Tew. Evidence for a glycoconjugate form of glutathione S-transferase pi. Int. J. Peptide Res. 37:565-571 (1991).
55. Nakagawa, K, N. Saijo, S. Tsuchida, M. Sakai, M. Tsunokawa, J. Yokota, M. Muramatsu, K. Sato, M. Terada, and K. D. Tew. Glutathione S-transferase π as determinant of drug resistance in transfectant cells lines. J. Biol. Chem. 265:4296-4301 (1990).
56. Alin, P., U. H. Danielson, and B. Mannervik. 4-Hydroxyalk-2-enals are substrates for glutathione S-transferase. FEBS Lett. 179:267-270, 1985.
57. Widersten, M., W. R. Pearson, A. Engstrom, and B. Mannervik. Heterologous expression of the allelic variant μ-class glutathione transferases μ and Φ Biochem. J. 276:519-524 (1991).
58. Schisselbauer, J. C., W. M. Hogan, K. A. Buetow, and K. D. Tew. Heterogeneity of glutathione S-transferase enzyme and gene expression in ovarian carcinoma. Pharmacogenetics 2:63-72 (1992).
59. Ranganathan, S., and K. D. Tew. Immunohistochemical localization of glutathione S-transferases α, μ and π in normal and tumor tissue from human colon. Carcinogenesis 12:2383-2387 (1991).
60. Tew, K. D.,M. L. Clapper, R. E. Greenberg, J. L. Weese, S. J. Hoffman, and T. M. Smith. Glutathione S-transferases in human prostate. Biochim. Biophys. Acta 926:8-15 (1987).
61. Hanigan, M. H., and W. A. Ricketts. Extracellular glutathione is a source of cysteine for cells that express γ-glutamyl transpeptidase. Biochemistry 32:6302-6306 (1993).
62. Mannervik, B., Y. C. Awasthi, P. G. Board, J. D. Hayes, C. Dillio, B. Ketterer, I. Listowsky, R. Morgenstern, M. Muramatsu, and W. R. Pearson. Nomenclature for human glutathione transferases (Letter). Biochem. J. 282:305-306 (1992).